Niclosamide topical - AntibioTx

Drug Profile

Niclosamide topical - AntibioTx

Alternative Names: ATx 201 - AntibioTx

Latest Information Update: 23 Jan 2017

Price : $50

At a glance

  • Originator AntibioTx
  • Class Anthelmintics
  • Mechanism of Action Nucleic acid nucleotide and nucleoside modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Atopic dermatitis; Eczema

Most Recent Events

  • 23 Jan 2017 Chemical structure information added
  • 05 Dec 2016 AntibioTx initiates enrolment in a phase I trial for Eczema and Atopic dermatitis in Austria
  • 01 Dec 2016 Phase-I/II clinical trials in Atopic dermatitis in Austria (Topical) (EudraCT2016-003501-33)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top